Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)

NCT02819479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Radiation Necrosis

Interventions

DRUG: 25% Mannitol
DRUG: Low-dose Intra-arterial Bevacizumab

Sponsor

Norton Healthcare

Collaborators

[object Object]